Evidence map›Paper›PMID 29166928›Full record

Trial reportBMC medicine2017

Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection - a double blind, randomised controlled trial in Burkina Faso.

Loretta Brabin, Stephen A Roberts, Sabine Gies, Andrew Nelson, Salou Diallo, Christopher J Stewart, Adama Kazienga, Julia Birtles, Sayouba Ouedraogo, Yves Claeys and 4 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01210040 (Malaria Risk Prior to and During Early Pregnancy in Nulliparous Women Receiving Long-term Weekly Iron and Folic Acid Supplementation), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01210040 nacompletednot on this map

Malaria Risk Prior to and During Early Pregnancy in Nulliparous Women Receiving Long-term Weekly Iron and Folic Acid Supplementation (WIFS): a Non-inferiority Randomized Controlled Trial

TypeinterventionalSponsorLiverpool School of Tropical MedicineRan2011 to 2014Enrolled1,959ConditionsMalariaArmsFolic Acid, Folic Acid and Iron
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Influence of cervicovaginal microbiota onMicrobial cell (Graz, Austria) · 2025
    Review
  6. Prevalence and clinical correlates ofFrontiers in cellular and infection microbiology · 2024
    Article
  7. Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 7 countries.

Loretta BrabinDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. loretta.brabin@manchester.ac.uk.ORCID 0000-0003-4478-6503
Stephen A RobertsCentre for Biostatistics, Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Sabine GiesDepartment of Biomedical Sciences, Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium.
Andrew NelsonFaculty of Health and Life Sciences, Northumberland Building, University of Northumbria, Newcastle-upon-Tyne, England.
Salou DialloClinical Research Unit, Institute for Research in Health Sciences, (IRSS-URCN), Nanoro, Burkina Faso.
Christopher J StewartMolecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Adama KaziengaClinical Research Unit, Institute for Research in Health Sciences, (IRSS-URCN), Nanoro, Burkina Faso.
Julia BirtlesCentral Manchester University Hospitals NHS Foundation Trust, Microbiology Department, Manchester, UK.
Sayouba OuedraogoClinical Research Unit, Institute for Research in Health Sciences, (IRSS-URCN), Nanoro, Burkina Faso.
Yves ClaeysClinical Trials Unit, Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium.
Halidou TintoMedical Research Council Unit (MRC), Banjul, Gambia.
Umberto d'AlessandroClinical Research Unit, Institute for Research in Health Sciences, (IRSS-URCN), Nanoro, Burkina Faso.
E Brian FaragherClinical Division, Liverpool School of Tropical Medicine, Liverpool, UK.
Bernard BrabinLiverpool School of Tropical Medicine and Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Institut de Recherche en Sciences de la Santé · BFManchester Academic Health Science Centre · GBBaylor College of Medicine · USInstituut voor Tropische Geneeskunde · BELiverpool School of Tropical Medicine · GBLondon School of Hygiene & Tropical Medicine · GBMedical Mission Institute · DENorthumbria University · GBUniversity of Liverpool · GB

Funding

Long-term WIFS and malaria risk in early pregnancy: a randomized controlled trialU01HD061234 · NICHD · TMLIVERPOOL SCHOOL OF TROPICAL MEDICINE · PI BRABIN, BERNARD JOHN · 2009 to 2014
$1.9M
National Institute of Child Health and Human Development Number U01HD061234-01A1; Supplementary -05S1 and -02S2),National Institutes of Health Office of Dietary Supplements U01HD061234-01A1; Supplementary -05S1 and -02S2
6 · The paper itself

Abstract

backgroundProvision of routine iron supplements to prevent anaemia could increase the risk for lower genital tract infections as virulence of some pathogens depends on iron availability. This trial in Burkina Faso assessed whether weekly periconceptional iron supplementation increased the risk of lower genital tract infection in young non-pregnant and pregnant women.

methodsGenital tract infections were assessed within a double blind, controlled, non-inferiority trial of malaria risk among nulliparous women, randomised to receive either iron and folic acid or folic acid alone, weekly, under direct observation for 18 months. Women conceiving during this period entered the pregnancy cohort. End assessment (FIN) for women remaining non-pregnant was at 18 months. For the pregnancy cohort, end assessment was at the first scheduled antenatal visit (ANC1). Infection markers included Nugent scores for abnormal flora and bacterial vaginosis (BV), T. vaginalis PCR, vaginal microbiota, reported signs and symptoms, and antibiotic and anti-fungal prescriptions. Iron biomarkers were assessed at baseline, FIN and ANC1. Analysis compared outcomes by intention to treat and in iron replete/deficient categories.

resultsA total of 1954 women (mean 16.8 years) were followed and 478 (24.5%) became pregnant. Median supplement adherence was 79% (IQR 59-90%). Baseline BV prevalence was 12.3%. At FIN and ANC1 prevalence was 12.8% and 7.0%, respectively (P < 0.011). T. vaginalis prevalence was 4.9% at FIN and 12.9% at ANC1 (P < 0.001). BV and T. vaginalis prevalence and microbiota profiles did not differ at trial end-points. Iron-supplemented non-pregnant women received more antibiotic treatments for non-genital infections (P = 0.014; mainly gastrointestinal infections (P = 0.005), anti-fungal treatments for genital infections (P = 0.014) and analgesics (P = 0.008). Weekly iron did not significantly reduce iron deficiency prevalence. At baseline, iron-deficient women were more likely to have normal vaginal flora (P = 0.016).

conclusionsPericonceptional weekly iron supplementation of young women did not increase the risk of lower genital tract infections but did increase general morbidity in the non-pregnant cohort. Unabsorbed gut iron due to malaria could induce enteric infections, accounting for the increased administration of antibiotics and antifungals in the iron-supplemented arm. This finding reinforces concerns about routine iron supplementation in highly malarious areas.

trial registrationTrial registration number NCT01210040 . Registered with Clinicaltrials.gov on 27 September 2010.

Indexed as

AdolescentAnemiaBurkina FasoDietary SupplementsDouble-Blind MethodFemaleFolic AcidFollow-Up StudiesHumansIronMalariaPregnancyPrenatal CarePrevalenceReproductive Tract InfectionsVaginaFolic AcidIronAdolescentsAntibioticsBurkina FasoIronLower genital tract infection

Identifiers

PMID29166928
PMCPMC5700548
OpenAlexW2768831790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.